How do gender differences impact the management and treatment of diabetic foot ulcers in patients with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gender Differences in Diabetic Foot Ulcers

Male patients with diabetes have a significantly higher risk of developing diabetic foot ulcers compared to women, with men experiencing approximately twice the ulceration rate (40% vs 19%), but once risk factors are present, both genders face equal risk of ulceration and should receive identical aggressive management. 1

Key Gender-Based Epidemiological Differences

Ulcer Development and Recurrence

  • Men demonstrate a 26% increased risk of ulcer recurrence compared to women (OR = 1.26,95% CI = 1.10-1.44), making male gender an independent risk factor for recurrent ulceration 2

  • In prospective studies, 40% of men developed plantar foot ulcers versus only 19% of women over 30 months, representing more than double the ulceration rate 1

Underlying Pathophysiological Differences

Men present with more severe baseline risk factors that explain their higher ulceration rates 1:

  • Significantly worse peripheral neuropathy: Men have higher Neuropathy Disability Scores (13 ± 8 vs 8 ± 7) and elevated Vibration Perception Thresholds (36 ± 17 V vs 23 ± 16 V) 1

  • Higher plantar pressures: Men exhibit peak foot pressures of 6.4 ± 3.4 kg/cm² compared to 5.0 ± 2.3 kg/cm² in women 1

  • Reduced joint mobility: Women maintain better subtalar joint mobility (26 ± 8 degrees vs 22 ± 10 degrees) and first metatarsal joint mobility (77 ± 23 degrees vs 69 ± 24 degrees), providing protective biomechanical advantages 1

Critical Clinical Implications for Management

Risk Stratification Must Be Gender-Neutral

Once neuropathy or other risk factors are present, women have identical odds ratios for ulceration as men, with similar risk profiles for high neuropathy scores (OR 8.3 for women vs 6.1 for men), elevated vibration perception thresholds (OR 8.9 vs 6.0), and high foot pressures (OR 3.0 vs 2.7) 1

Healing Outcomes Show Gender Disparity

  • Female gender is independently associated with improved healing outcomes, with women demonstrating a healing risk ratio of 2.01 (95% CI 1.20-3.40) compared to men 3

  • Male gender, along with initial ulcer size >2 cm² and infection during treatment, increases the risk of non-closure after 12 weeks of care 3

Management Algorithm Should Address Gender-Specific Risk Factors

For male patients 2, 1:

  • Implement more aggressive neuropathy screening with lower thresholds for intervention
  • Prescribe pressure-offloading footwear earlier given higher baseline plantar pressures
  • Intensify recurrence prevention strategies given 26% increased recurrence risk
  • Screen more frequently for smoking history (independent recurrence risk factor, OR = 1.18)

For female patients 1, 3:

  • Do not underestimate risk once neuropathy or other risk factors develop—apply identical aggressive management as for men
  • Leverage better baseline joint mobility through appropriate footwear that maintains this advantage
  • Recognize superior healing potential but maintain vigilance for other risk factors

Common Pitfalls to Avoid

  • Never assume women are at lower risk once they present with neuropathy or foot deformity—the protective gender advantage disappears entirely in the presence of established risk factors 1

  • Do not overlook social factors: Living alone increases ulcer recurrence risk (OR = 1.86), which may disproportionately affect one gender depending on demographics 2

  • Male patients require enhanced surveillance for diabetic retinopathy (OR = 1.59), diabetic nephropathy (OR = 1.37), peripheral neuropathy (OR = 1.78), foot deformity (OR = 2.51), and peripheral arterial disease (OR = 3.10)—all independent recurrence risk factors 2

Essential Management Components Regardless of Gender

Both genders require identical multidisciplinary approaches including 4:

  • Strict glycemic control (HgbA1c optimization directly impacts healing) 3
  • Mechanical offloading for plantar ulcers (OR = 2.44 for recurrence) 2
  • Aggressive infection control (infection increases non-closure risk ratio to 2.9) 3
  • Addressing peripheral arterial disease (strongest recurrence predictor, OR = 3.10) 2

Related Questions

What is the most appropriate way to assess a diabetic patient with a foot ulcer and intact distal pulses?
What is the best treatment plan for diabetic ulcers on the lower extremities?
What causes secondary infection in a diabetic patient with a medically managed foot ulcer?
How is the San Elian classification system interpreted in diabetic foot?
What is the best management plan for a 66-year-old male patient with diabetes presenting with bilateral redness on the lateral aspect of both feet, at risk for skin breakdown, who is requesting diabetic shoes?
What are the next steps for a patient with major depressive disorder, premenstrual dysphoric disorder (PMDD), posttraumatic stress disorder (PTSD), and insomnia disorder, taking venlafaxine (Effexor), bupropion (Wellbutrin), and hydroxyzine (Vistaril), with cyclical mood changes and depressive episodes?
What is the likely diagnosis and treatment for unilateral ear itchiness with yellow watery discharge?
What could be the cause of recurrent red lips, burning, pain, minimal swelling, and irritation with intermittent flares in an adult with a history of ineffective treatment with Valtrex (valacyclovir) and mupirocin, but temporary relief with steroids?
What antibiotics are safe to use during the first trimester of pregnancy?
Is a negative Rapid Plasma Reagin (RPR) test at 41 days and a negative treponemal test at 49 days post-exposure considered conclusive for ruling out syphilis?
Can Macrobid (nitrofurantoin) be used in a pregnant woman during the first trimester for a urinary tract infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.